[1] Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal result of the Hypertension Optimal Treatment(HOT) randomized trial[J]. Lancet, 1998, 351(9118): 1755-1762. [2] Meredith PA, Elliott HL. FDA guidelines on trough/peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration[J]. J Cardiovasc Pharmacol, 1994, 23(suppl 5): S26-30. [3] JCS Joint Working Group. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring(ABPM)(JCS 2010)[J]. Circ J, 2012, 76(2): 508-519. [4] de Roa ER, Botero R, Octavio JA, et al. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump[J]. Am J Ther, 2007, 14(2): 140-146. [5] Radauceanu A, Virion JM, Boivin JM, et al. Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril[J]. Fundam Clin Pharmacol, 2002, 16(6): 545-554. [6] Omboni S, Parati G, Zanchetti A, et al. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects[J]. J Hypertens, 1995, 13(10): 1105-1112. [7] Meredith PA, Elliott HL. Trough/peak ratios for antihypertensive agents: methodological considerations[J]. Blood Press Monit, 1996, 1(3): 293-297. [8] Parati G, Omboni S, Rizzoni D, et al. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension[J]. J Hypertens, 1998, 16(11): 1685-1691. [9] Detry JMR, Block P, De Backer G, et al. Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension[J]. Eur J Clin Pharmacol, 1995, 48(3/4): 314. [10] Neutel JM. The importance of 24-h blood pressure control[J]. Blood Press Monit, 2001, 6(1): 9-16. [11] Soucek M, Rihacek I, Frana P. A comparison of the trough-to-peak ratio of cardio-selective beta-blockers in patients with newly diagnosed hypertension[J]. Blood Press Monit, 2006, 11(6): 337-342. [12] Zannad F, Bernaud CM, Fay R. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group[J]. J Hypertens, 1999, 17(1): 137-46. [13] Campo C, Saavedra J, Segura J, et al. Correlations of smoothness index and trough-to-peak ratio with left ventricular mass index changes induced by lercanidipine in hypertensive patients. A pilot trial[J]. Minerva Med, 2005, 96(5): 365-371. |